One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low ...

Antimicrobials, vaccines, and anti-inflammatories associated with reduced risk for Alzheimer disease and dementia.

The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

The geroscience hypothesis focuses on extending the healthy lifespan by targeting aging mechanisms. Recent advances in ...

List of Partners (vendors) Required cookies to perform essential website functions. These cookies are necessary for our websites to work. Functions include log-in, saving language preferences, ...

Blockbuster diabetes drug Ozempic is on the list. That means the federal government and the pharmaceuticals industry are about to go head-to-head once again. The Centers for Medicare and Medicaid ...

had until Feb. 1 to release the list, but officials said the agency had routinely been ahead of schedule throughout the process. Coupled with the first 10 drugs that have already been negotiated ...

The Biden administration released the list of 15 drugs on Friday in one of its final acts of healthcare policy before President-elect Donald Trump takes office on Jan. 20. Publication of the list ...

Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical trial has demonstrated the potential of focused ultrasound to safely ...